Option Care Health, Inc. (OPCH) Cash Flow Statement

The OCF/NI ratio of 3.41 in 2026Q2 suggests strong cash generation relative to earnings, but the negative ratio in 2026Q1 indicates that working capital swings, not underlying profitability, drive cash flow. The large working capital changes, such as $47.9M positive in 2026Q2 versus -$89.7M in 2026Q1, appear to be timing-related, likely due to billing cycles and payor mix. Investors should monitor whether these swings smooth out over time or signal structural collection issues.

The extreme quarterly FCF swings are primarily driven by working capital changes, not capex, which remains consistently low at under 1.3% of revenue. The average FCF margin over the last four quarters is roughly 6%, but the volatility suggests that quarterly comparisons are misleading. The positive FCF in 2026Q2 and 2025Q3 indicates that the business can generate strong cash when working capital normalizes, but the negative quarters in 2026Q1 and 2025Q1 highlight the need for careful cash flow management.

With capex consistently below $20M per quarter against revenue exceeding $1.4B, OPCH's capital intensity is remarkably low, which supports strong FCF conversion when working capital is favorable. This suggests that the company's infrastructure, including its pharmacy network and infusion suites, is already in place and requires only modest maintenance spending. The low capex also implies that growth is primarily organic and does not require significant upfront investment, which may be a competitive advantage.

The working capital swings are the primary driver of OPCH's cash flow volatility, with positive changes in some quarters and negative in others. This pattern suggests that the company's billing and collection cycles are lumpy, possibly due to the timing of insurance reimbursements and drug purchases. The negative working capital changes in Q1 quarters (2024Q1, 2025Q1, 2026Q1) may indicate seasonal patterns, such as higher payables or slower collections at the start of the year. Investors should expect continued volatility and focus on annual trends rather than quarterly figures.

The company has consistently repurchased shares each quarter, with buybacks ranging from $17.5M to $153.0M, suggesting a commitment to returning capital to shareholders. However, the large buyback in 2026Q2 ($153.0M) exceeded operating cash flow of $183.6M, which may indicate that the company is using cash reserves or debt to fund repurchases. Given the low dividend yield and no dividends paid, buybacks appear to be the primary method of capital return, but the sustainability of this pace depends on cash flow stability.

The cumulative OCF of $753.9M versus net income of $518.5M suggests that the company's earnings are backed by real cash generation, with a cumulative OCF/NI ratio of 1.45. This indicates that non-cash charges like D&A and SBC, which total $153.3M and $94.6M respectively, are more than offset by working capital inflows. However, the volatility in working capital means that this cumulative surplus may not be evenly distributed, and investors should monitor whether this trend continues.